Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Severe Dengue

Managing the severely ill dengue patients – Adult and Paediatric Intensivists

ADVA

92 minutes
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19

Takeda

2 minutes
Dengue and post-infection fatigue: findings from a prospective cohort study

Takeda

2 minutes
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study

Takeda

2 minutes
Case presentations in severe dengue: contemporary approaches to clinical management

Medscape

45 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda